Latest news
Vaxart Inc (VXRT) Advances COVID-19 Trial with Attractive Valuation Metrics - GuruFocusGuruFocus · Sat, 08 Aug 2026 03:40:15 GMTVXRT: Strong safety data, BARDA funding, and prudent financial strategy support pipeline progress - TradingViewTradingView · Fri, 07 Aug 2026 21:53:45 GMTVXRT 10-Q & SEC Filings - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 04:53:28 GMTVXRT 8-K & SEC Filings - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 04:51:11 GMTVXRT: Positive safety data, BARDA funding, and cash runway into Q2 2027 amid lower revenue - TradingViewTradingView · Thu, 06 Aug 2026 23:45:26 GMTVaxart Provides Business Update and Reports Second Quarter 2026 Financial Results - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Vaxart (VXRT) Investors: 5 Days to Application Deadline in Securities Fraud Class Action, Investors with Significant Losses Encouraged to Contact the Firm - TMX NewsfileTMX Newsfile · Sun, 02 Aug 2026 06:32:59 GMTVaxart, Inc. Actuals & Estimates (OTC:VXRT) - TradingViewTradingView · Sat, 01 Aug 2026 06:27:18 GMT